Cleared Traditional

K202267 - Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles (FDA 510(k) Clearance)

Dec 2020
Decision
142d
Days
Class 2
Risk

K202267 is an FDA 510(k) clearance for the Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles. This device is classified as a Source, Brachytherapy, Radionuclide (Class II - Special Controls, product code KXK).

Submitted by Isoray Medical, Inc. (Richland, US). The FDA issued a Cleared decision on December 31, 2020, 142 days after receiving the submission on August 11, 2020.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K202267 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2020
Decision Date December 31, 2020
Days to Decision 142 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code KXK - Source, Brachytherapy, Radionuclide
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.5730